In this article, we will discuss Mogamulizumab (Dosage Overview). So, let’s get started.
Mogamulizumab is indicated for the treatment of adult patients with relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS) after at least one prior systemic therapy.
The recommended dose of Mogamulizumab is 1 mg/kg administered as an intravenous infusion over at least 60 minutes. Administer on days 1, 8, 15, and 22 of the first 28-day cycle, then on days 1 and 15 of each subsequent 28-day cycle until disease progression or unacceptable toxicity.
Administer Mogamulizumab within 2 days of the scheduled dose. If a dose is missed, administer the next dose as soon as possible and resume dosing schedule.
Do not administer Mogamulizumab subcutaneously or by rapid intravenous administration.
Administer premedication with diphenhydramine and acetaminophen for the first Mogamulizumab infusion.